This new 795-page report contains 61 tables, and provides a comprehensive analysis of the 2021-2025 POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global 2021-2025 POC infectious disease testing market.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the publisher's proprietary data files.
Contains 795 pages and 61 tables
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of five 2021-2025 POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment
- Physician Offices/Group Practices
- Emergency Rooms
- Ambulatory Care Centers
- Surgery Centers
- Birth Centers
Sales and Market Share Analysis
- Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
- Analysis of infectious disease diagnostic tests performed in 2021-2025 POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
- Emerging technologies and their applications for 2021-2025 POC testing.
- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive Assessments
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for 2021-2025 POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the publisher's proprietary data files.
Contains 795 pages and 61 tables
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
